Annals of Maxillofacial Surgery · 2022 · 17 citations · 19 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyNeoplasiaCancer BiomarkersCancer MetabolismCancer TranscriptomicsMolecular Tumor ProfilingOral Cancer BiomarkersSquamous Cell CarcinomaCancer Genomics DatabasesMessenger Rna Expression SignaturesMitochondrial Respiratory Complex IiiOncogene Expression AnalysisPrognostic Marker EvaluationReactive Oxygen Species GenerationReal-time Polymerase Chain Reaction (Pcr)Tumor-node-metastasis Staging
Introduction: Cytochrome C1 (CYC1) is an important subunit of mitochondrial complex III and plays a vital role in oxidative phosphorylation (OXPHOS) and reactive oxygen species generation. Overexpression of the CYC1 gene has been implicated in cancer development and its prognosis previously, but unexplored in head-and-neck squamous cell carcinomas (HNSCC), especially oral squamous cell carcinoma (OSCC). Materials and Methods: CYC1 m-RNA expression and gene alterations were assessed using the Cancer Genome Atlas dataset in HNSCC and validated in OSCC tissues using real-time polymerase chain reaction (RT-PCR). The protein–protein interaction (PPI) network and functional enrichment pathways were also analysed. Results: A thorough analysis of the TCGA (The Cancer Genome Atlas) database revealed that CYC1 was overexpressed in the HNSCC cases and the increased expression correlated with several parameters which involve the prediction of advanced diseases such as histopathological grade, tumour-node-metastasis staging, and nodal metastases ( P < 0.05). The expression of CYC1 was validated using RT-PCR showing significant upregulation ( P < 0.05) in OSCC tissue samples compared to the normal tissue counterparts. PPI network and functional analysis show the prominent role of CYC1 in OXPHOS, especially in electron transport chain III complex regulation. Discussion: The study revealed that CYC1 is highly expressed in HNSCC, and is validated in the OSCC patient tissue samples compared to the normal counterparts and associated with advanced disease stages and grade of the tumour. CYC1 could be a novel promising therapeutic and prognostic marker in HNSCC, especially in OSCC.
19
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling · 2013 · 15.9K citations · Full text
Medicine, Bioinformatics, Oncology +17
Hallmarks of Cancer: New Dimensions
Cancer Discovery · 2022 · 9.1K citations · Full text
Medicine, Cancer Biology, Oncology +17